meta_pixel
Tapesearch Logo
Log in
Plenary Session

3.21 Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7789 Ratings

🗓️ 13 November 2020

⏱️ 184 minutes

🧾️ Download transcript

Summary

First up this week we interview constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health & Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocacy. Cost Implications: doi.org/10.1001/jamainternmed.2020.5921 Back us on Patreon! www.patreon.com/plenarysession Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome. I'm Dr. Vinay Prasad. I'm a hematologist, oncologist, and I'm associate professor of medicine at the University of California, San Francisco. In my professional life, I see patients, I teach trainees, and I do research in health care policy. This is Plenary Session.

0:23.4

Plenary Session is a podcast at the intersection of medicine, oncology, and health policy,

0:27.8

and you're listening to Season 3.

0:31.1

On this week's episode.

0:33.5

This week on Plenary Session, you're in for a real treat.

0:35.7

I've got, yes, this week we're going to talk about a range of issues. First, I have Professor Leah Littman.

0:41.5

Leah Littman is assistant professor of law at the University of Michigan. She's a former clerk

0:45.2

for Justice Anthony Kennedy. She's going to talk about something that we have broached on this

0:50.4

podcast but have not delved into head-on. We've talked a lot about Norman Wang and whether or not the retribution he faced was commensurate

0:59.7

with his crime of writing that paper.

1:02.2

And I felt, still feel that there are some issues with the process of how he was treated.

1:07.7

But along the way, we've been detoured from the bigger question, which is, what is the

1:13.2

legal question of affirmative action? What is the law currently? Which direction is the law going?

1:18.8

And why the direction the law is going may be flawed. Professor Littman is a thoughtful constitutional

1:24.5

law scholar who's going to take us through this argument. This is a very

1:27.7

important discussion. It's important not to forget how a debate could have occurred on this

1:33.2

issue instead of being derailed by the process of how this person was treated in response to his views.

1:39.7

And listen to Professor Littman describe how law professors with views very similar to Mr. Norman

1:45.7

Wang are treated in the legal profession.

1:48.4

You won't want to miss that discussion.

1:49.9

Next.

1:51.0

We can't forget this is still an oncology podcast, and God willing, we will be back to

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.